Monday, December 10, 2012
Northwest Biotherapeutics Inc., of Bethesda, Md., said it priced an underwritten public offering of 3 million shares of common stock, and warrants to purchase up to an aggregate 1.5 million shares of common stock, at $4 per share and $0.01 per warrant. The warrants have a per-share exercise price of $5, are exercisable immediately, and expire five years from the date of issuance.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.